CHIP News and Research

RSS

Olympus scanR high-content screening station v. 3.2 brings improved image quality with award-winning X Line objectives

The scanR high-content screening (HCS) station version 3.2 delivers improved image quality, better quantitative data, support for challenging segmentation and classification applications and increased speed to help life science researchers maximize the information they get from their samples.

From Evident Corporation - Life Sciences 20 Jul 2020

Emerging hydrogel material could improve oral drug delivery

An emerging hydrogel material with the capacity to degrade and spontaneously reform in the gastrointestinal tract could help researchers develop more effective methods for oral drug delivery.

16 Jul 2020

Fully automated chip can reliably determine blood type within minutes

The need to first zero in on a blood group can delay blood transfusions in emergency situations, and this in turn can prove fatal.

13 Jul 2020

GE Healthcare selects UH to evaluate new mobile x-ray system enabled with Critical Care Suite

GE Healthcare chose University Hospitals Cleveland Medical Center in November of 2019 as the first hospital in the US to evaluate its new mobile x-ray system enabled with Critical Care Suite, the world's first on-device AI solution for triage & notification of critical findings and quality errors.

12 Jul 2020

Colorado, like other states, trims health programs amid health crisis

As a teenager, Paulina Castle struggled for years with suicidal thoughts. When her mental health was at its most fragile, she would isolate herself, spending days in her room alone.

10 Jul 2020

Researchers to create AI-based pill to precisely diagnose gastrointestinal cancers

A team led by University of Saskatchewan (USask) researcher Khan Wahid has been awarded $250,000 from the federal New Frontiers in Research Fund to create a new pill-sized capsule that uses artificial intelligence (AI)-enabled sensing to diagnose gastrointestinal cancers and bleeding earlier and more precisely than is currently possible.

9 Jul 2020

Study reveals how overactive immune cells aggravate heart valve disease

A new study using organ-on-a-chip technology reveals how overactive immune cells aggravate heart valve disease and how this damaging hyperactivity could potentially be controlled.

8 Jul 2020

Cell 'membrane on a chip' could help test potential drug candidates for COVID-19

Researchers have developed a human cell 'membrane on a chip' that allows continuous monitoring of how drugs and infectious agents interact with our cells, and may soon be used to test potential drug candidates for COVID-19.

6 Jul 2020

New technique could help fight the global threat of antibiotic resistance

A new technique could help reduce antibiotic prescribing by predicting which drugs could be effective in fighting bacteria within minutes.

2 Jul 2020

New technique reduces cell damage, improves IVF rates

Motile sperm are difficult to collect with a conventional cell sorter because they are vulnerable to physical damage.

2 Jul 2020

NUS researchers develop portable COVID-19 micro-PCR diagnostic system

COVID-19 screening can soon be conducted directly at various testing stations, and patients can get their test results in about an hour from the time they get a nasal swab.

29 Jun 2020

WFIRM and Oracle Health Sciences team up to pair Body-on-a-Chip with data analytics

The Wake Forest Institute for Regenerative Medicine and Oracle Health Sciences have teamed as part of the Innovation Quarter's iQ Healthtech Labs to develop a consortium of industry, government, and academic members that will study novel approaches to establishing the safety of new drugs that are nearing clinical investigation in humans and FDA approval.

26 Jun 2020

G6PD enzyme offers a promising therapeutic target in autoimmune diseases

A team from the University of Valencia, the La Fe Hospital Health Research Institute, and the INCLIVA Institute have participated in the identification of an enzyme (G6PD) as a possible therapeutic target in autoimmune diseases or in controlling exacerbated inflammatory responses such as the one caused by SARS-CoV-2 infection.

25 Jun 2020

New device monitors health conditions using a person's sweat

A device that monitors health conditions in the body using a person's sweat has been developed by Penn State and Xiangtan University researchers, according to Huanyu "Larry" Cheng, assistant professor of engineering science and mechanics, Penn State.

23 Jun 2020

New technology detects breast cancer using tears

Kobe University and System Instruments Co., Ltd. researchers have developed TearExo; new technology to detect breast cancer using the exosomes found in tears as biomarkers. Exosomes are a subtype of extracellular vesicles.

19 Jun 2020

Global experts develop open-source N95 face mask

In one of the latest COVID-19 response projects at the University of Massachusetts Amherst, the Advanced Digital Design and Fabrication laboratory is collaborating with a global network of design, engineering and manufacturing experts to help develop an open-source N95 face mask.

18 Jun 2020

Celltrion announces plans to launch COVID-19 point-of-care antigen testing kit

Celltrion Group today announced plans to expand its diagnostic portfolio for SARS-CoV-2, the virus causing COVID-19, in its efforts to improve access to COVID-19 testing and help prevent the further spread of coronavirus infection worldwide.

17 Jun 2020

Researchers receive federal funding to rapidly repurpose FDA-approved drugs for COVID-19

Researchers at the University of Maryland School of Medicine will be partnering on an agreement funded by the federal government's Defense Advanced Research Projects Agency (DARPA) to rapidly test hundreds of drugs, approved and marketed for other conditions, to see whether any can be repurposed to prevent or treat COVID-19.

16 Jun 2020

Research demonstrates novel pathway regulating the underlying mechanism of NASH

CN Bio, a leading cell culture company that has developed single and multi-organ microphysiological systems that improve the accuracy and efficiency of drug discovery, today announced the publication of co-authored research led by researchers at the University of Cambridge in Nature Metabolism, identifying a novel pathway that regulates the underlying mechanism of Non-Alcoholic Steatohepatitis, potentially a new therapeutic target.

10 Jun 2020

Research team identifies key ingredients for producing high-value chemical compounds

Researchers have identified key ingredients for producing high-value chemical compounds in an environmentally friendly fashion: repurposed enzymes, curiosity, and a little bit of light.

8 Jun 2020